Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451

被引:10
作者
Firouzian, Azadeh [1 ]
Whittington, Alex [2 ]
Searle, Graham E. [1 ]
Koychev, Ivan [3 ]
Zamboni, Giovanna [4 ]
Lovestone, Simon [3 ]
Gunn, Roger N. [1 ,2 ,5 ]
机构
[1] Imperial Coll London, Hammersmith Hosp, Imanova Ltd, Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England
[2] Imperial Coll London, Dept Med, Fac Med, South Kensington Campus, London SW7 2AZ, England
[3] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England
[4] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England
[5] Univ Oxford, Dept Engn Sci, Oxford, England
来源
EJNMMI RESEARCH | 2018年 / 8卷
基金
英国医学研究理事会;
关键词
Alzheimer's disease; PET; Amyloid; Tau; Modelling; POSITRON-EMISSION-TOMOGRAPHY; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; NEUROFIBRILLARY PATHOLOGY; PET RADIOTRACER; F-18-AV-1451; RECOMMENDATIONS; BINDING; TRACER;
D O I
10.1186/s13550-018-0371-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: AD is a progressive neurodegenerative disorder that is associated with the accumulation of two different insoluble protein aggregates, A beta plaques and hyperphosphorylated tau. This study aimed to investigate the optimal acquisition and quantification of [F-18]AV45 and [F-18]AV1451 to image A beta and tau, respectively, in subjects with AD. Fifteen subjects with early stage AD underwent a T1-weighted structural MRI and two dynamic PET scans to image A beta (60 min, [F-18]AV45) and tau (120 min, [F-18]AV1451). Both dynamic BPND and static SUVR outcome measures were calculated and compared for 12 out of 15 subjects who completed 60 min of the A beta PET scan and at least 110 min of the tau PET scan. The SRTM and reference Logan graphical analysis were applied to the dynamic data to estimate regional BPND values and SUVR ratios from the static data. Optimal acquisition windows were explored for both the dynamic and static acquisitions. In addition, the spatial correlation between regional A beta and tau signals was explored. Results: Both the SRTM and graphical analysis methods showed a good fit to the dynamic data for both A beta and tau dynamic PET scans. Mean regional BPND estimates became stable 30 min p.i. for [F-18]AV45 and 80 min p.i. for [F-18]AV1451. Time stability analysis of static SUVR data showed that the outcome measure starts to become stable for scan windows of 30-50 min p.i. for [F-18]AV45 and 80-100 min p.i. for [F-18]AV1451. The results from these time windows correlated well with the results from the full dynamic analysis for both tracers (R-2 = 0.74 for [F-18]AV45 and R-2 = 0.88 for [F-18]AV1451). There was a high correlation between amyloid uptake estimate using both dynamic analysis methods in thalamus and tau uptake in thalamus, hippocampus and amygdala. Conclusions: Short static PET scans at appropriate time windows provided SUVR values which were in reasonable agreement with BPND values calculated from dynamic scans using SRTM and reference Logan. These simplified methods may be appropriate for classification and intervention studies, although caution should be employed when considering interventional studies where blood flow and extraction could change.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
    Xia, Chenjie
    Makaretz, Sara J.
    Caso, Christina
    McGinnis, Scott
    Gomperts, Stephen N.
    Sepulcre, Jorge
    Gomez-Isla, Teresa
    Hyman, Bradley T.
    Schultz, Aaron
    Vasdev, Neil
    Johnson, Keith A.
    Dickerson, Bradford C.
    JAMA NEUROLOGY, 2017, 74 (04) : 427 - 436
  • [22] [18F]AV-1451 Binding and Postmortem Pathology of CBD
    Coakeley, Sarah
    Ang, Lee Cyn
    Jansen, Gerard H.
    Cho, Sang Soo
    Lang, Anthony E.
    Houle, Sylvain
    Kalia, Lorraine V.
    Strafella, Antonio P.
    MOVEMENT DISORDERS, 2018, 33 (08) : 1360 - 1361
  • [23] Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
    Wooten, Dustin W.
    Guehl, Nicolas J.
    Verwer, Eline E.
    Shoup, Timothy M.
    Yokell, Daniel L.
    Zubcevik, Nevena
    Vasdev, Neil
    Zafonte, Ross D.
    Johnson, Keith A.
    El Fakhri, Georges
    Normandin, Marc D.
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 484 - 491
  • [24] Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease
    Tetzloff, Katerina A.
    Graff-Radford, Jonathan
    Martin, Peter R.
    Tosakulwong, Nirubol
    Machulda, Mary M.
    Duffy, Joseph R.
    Clark, Heather M.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Spychalla, Anthony J.
    Drubach, Daniel A.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (04) : 1713 - 1724
  • [25] [18F]FDG, [11C]PiB, and [18F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline
    Okonkwo, David O.
    Puffer, Ross C.
    Minhas, Davneet S.
    Beers, Sue R.
    Edelman, Kathryn L.
    Sharpless, Jane
    Laymon, Charles M.
    Lopresti, Brian J.
    Benso, Steven
    Puccio, Ava M.
    Pathak, Sudhir
    Ikonomovic, Milos D.
    Mettenburg, Joseph M.
    Schneider, Walter
    Mathis, Chester A.
    Mountz, James M.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [26] 18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes
    Vasilevskaya, Anna
    Anastassiadis, Chloe
    Thapa, Simrika
    Taghdiri, Foad
    Khodadadi, Mozhgan
    Multani, Namita
    Rusjan, Pablo
    Ozzoude, Miracle
    Tarazi, Apameh
    Mushtaque, Asma
    Wennberg, Richard
    Houle, Sylvain
    Green, Robin
    Colella, Brenda
    Vasdev, Neil
    Blennow, Kaj
    Zetterberg, Henrik
    Karikari, Thomas
    Sato, Christine
    Moreno, Danielle
    Rogaeva, Ekaterina
    Mikulis, David
    Davis, Karen Deborah
    Tator, Charles
    Tartaglia, Maria Carmela
    JOURNAL OF NEUROLOGY, 2024, : 6068 - 6079
  • [27] In vivo imaging of tau deposition in Alzheimer's disease using both [18F]-THK5317 and [18F]-S16: A pilot human study
    Fu, Liping
    Zhang, Jinming
    Zhou, Kaixiang
    Zhang, Xiaojun
    Xie, Hengge
    Zhu, Mingwei
    Cui, Mengchao
    Wang, Ruimin
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [28] Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET
    Hammes, Jochen
    Leuwer, Isabel
    Bischof, Gerard N.
    Drzezga, Alexander
    van Eimeren, Thilo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (13) : 2249 - 2256
  • [29] Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech
    Utianski, Rene L.
    Martin, Peter R.
    Botha, Hugo
    Schwarz, Christopher G.
    Duffy, Joseph R.
    Petersen, Ronald C.
    Knopman, David S.
    Clark, Heather M.
    Butts, Alissa M.
    Machulda, Mary M.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Whitwell, Jennifer L.
    Josephs, Keith A.
    CORTEX, 2020, 124 : 33 - 43
  • [30] Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging
    Baker, Suzanne L.
    Lockhart, Samuel N.
    Price, Julie C.
    He, Mark
    Huesman, Ronald H.
    Schonhaut, Daniel
    Faria, Jamie
    Rabinovici, Gil
    Jagust, William J.
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 332 - 338